AAAAAA
Results: 26-50/66
Authors:
Englert, J
Stark, H
Longa, L
Trebin, HR
Citation: J. Englert et al., Influence of fluctuations on the phase diagram of chiral nematic liquid crystals, PHYS REV E, 61(3), 2000, pp. 2759-2768
Authors:
Borstnik, A
Stark, H
Zumer, S
Citation: A. Borstnik et al., Temperature-induced flocculation of colloidal particles immersed into the isotropic phase of a nematic liquid crystal, PHYS REV E, 61(3), 2000, pp. 2831-2839
Authors:
Saravolac, EG
Ludkovski, O
Skirrow, R
Ossanlou, M
Zhang, YP
Giesbrecht, C
Thompson, J
Thomas, S
Stark, H
Cullis, PR
Scherrer, P
Citation: Eg. Saravolac et al., Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity, J DRUG TAR, 7(6), 2000, pp. 423-437
Authors:
Haddad, KC
Stark, H
Galatsanos, NP
Citation: Kc. Haddad et al., Constrained FIR filter design by the method of vector space projections, IEEE CIR-II, 47(8), 2000, pp. 714-725
Authors:
Tam, P
Monck, M
Lee, D
Ludkovski, O
Leng, EC
Clow, K
Stark, H
Scherrer, P
Graham, RW
Cullis, PR
Citation: P. Tam et al., Stabilized plasmid-lipid particles for systemic gene therapy, GENE THER, 7(21), 2000, pp. 1867-1874
Authors:
Sasse, A
Stark, H
Ligneau, X
Elz, S
Reidemeister, S
Ganellin, CR
Schwartz, JC
Schunack, W
Citation: A. Sasse et al., (Partial) agonist/antagonist properties of novel diarylalkyl carbamates onhistamine H-3 receptors, BIO MED CH, 8(5), 2000, pp. 1139-1149
Authors:
Stark, H
Ligneau, X
Sadek, B
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Citation: H. Stark et al., Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H-3-receptor antagonists, BIOORG MED, 10(20), 2000, pp. 2379-2382
Authors:
Stark, H
Citation: H. Stark, Convenient procedures for synthesis of ciproxifan, a histamine H-3-receptor antagonist, ARCH PHARM, 333(9), 2000, pp. 315-316
Authors:
Bischof, A
Stark, H
Wagner, T
Scheich, H
Citation: A. Bischof et al., The inhibitory influence of an acquired escape strategy on subsequent avoidance learning in gerbils, NEUROSCI L, 281(2-3), 2000, pp. 175-178
Authors:
Stark, H
Rodnina, MV
Wieden, HJ
van Heel, M
Wintermeyer, W
Citation: H. Stark et al., Large-scale movement of elongation factor G and extensive conformational change of the ribosome during translocation, CELL, 100(3), 2000, pp. 301-309
Authors:
van Tiggelen, B
Stark, H
Citation: B. Van Tiggelen et H. Stark, Nematic liquid crystals as a new challenge for radiative transfer, REV M PHYS, 72(4), 2000, pp. 1017-1039
Authors:
Kiec-Kononowicz, K
Wiecek, M
Sasse, A
Ligneau, X
Elz, S
Ganellin, CR
Schwartz, JC
Stark, H
Schunack, W
Citation: K. Kiec-kononowicz et al., Importance of the lipophilic group in carbamates having histamine H-3-receptor antagonist activity, PHARMAZIE, 55(5), 2000, pp. 349-355
Authors:
Reidemeister, S
Stark, H
Ligneau, X
Ganellin, CR
Schwartz, JC
Schunack, W
Citation: S. Reidemeister et al., Substituted N-phenylcarbamates as histamine H-3 receptor antagonists with improved in vivo potency, PHARMAZIE, 55(2), 2000, pp. 83-86
Authors:
Morisset, S
Rouleau, A
Ligneau, X
Gbahou, F
Tardivel-Lacombe, J
Stark, H
Schunack, W
Ganellin, CR
Schwartz, JC
Arrang, JM
Citation: S. Morisset et al., High constitutive activity of native H-3 receptors regulates histamine neurons in brain, NATURE, 408(6814), 2000, pp. 860-864
Authors:
Rouleau, A
Stark, H
Schunack, W
Schwartz, JC
Citation: A. Rouleau et al., Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H-3-receptor agonist prodrug, J PHARM EXP, 295(1), 2000, pp. 219-225
Authors:
Meissner, U
Dube, P
Harris, JR
Stark, H
Markl, J
Citation: U. Meissner et al., Structure of a molluscan hemocyanin didecamer (HtH1 from Haliotis tuberculata) at 12 angstrom resolution by cryoelectron microscopy, J MOL BIOL, 298(1), 2000, pp. 21-34
Authors:
Stark, H
Sadek, B
Krause, M
Huls, A
Ligneau, X
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Citation: H. Stark et al., Novel histamine H-3-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds, J MED CHEM, 43(21), 2000, pp. 3987-3994
Authors:
Sasse, A
Sadek, B
Ligneau, X
Elz, S
Pertz, HH
Luger, P
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Stark, H
Citation: A. Sasse et al., New histamine H-3-receptor ligands of the proxifan series: Imoproxifan andother selective antagonists with high oral in vivo potency, J MED CHEM, 43(17), 2000, pp. 3335-3343
Authors:
Stark, H
Bischof, A
Wagner, T
Scheich, H
Citation: H. Stark et al., Stages of avoidance strategy formation in gerbils are correlated with dopaminergic transmission activity, EUR J PHARM, 405(1-3), 2000, pp. 263-275
Authors:
Ligneau, X
Morisset, S
Tardivel-Lacombe, J
Gbahou, F
Ganellin, CR
Stark, H
Schunack, W
Schwartz, JC
Arrang, JM
Citation: X. Ligneau et al., Distinct pharmacology of rat and human histamine H-3 receptors: role of two amino acids in the third transmembrane domain, BR J PHARM, 131(7), 2000, pp. 1247-1250
Authors:
Hippler, H
Siefke, M
Stark, H
Troe, J
Citation: H. Hippler et al., New studies of the unimolecular reaction NO2 reversible arrow O+NO. Part 1. High pressure range of the O+NO recombination between 200 and 400 K, PCCP PHYS C, 1(1), 1999, pp. 57-61
Authors:
Harding, LB
Stark, H
Troe, J
Ushakov, VG
Citation: Lb. Harding et al., New studies of the unimolecular reaction NO2 reversible arrow O+NO. Part 2. Relation between high pressure rate constants and potential parameters, PCCP PHYS C, 1(1), 1999, pp. 63-72
Authors:
Stark, H
Stelzer, J
Bernhard, R
Citation: H. Stark et al., Water droplets in a spherically confined nematic solvent: A numerical investigation, EUR PHY J B, 10(3), 1999, pp. 515-523
Authors:
Stark, H
Citation: H. Stark, Director field configurations around a spherical particle in a nematic liquid crystal, EUR PHY J B, 10(2), 1999, pp. 311-321
Authors:
Stark, H
Citation: H. Stark, Foreign policy for German unity, INT POLITIK, 54(11), 1999, pp. 53-55